Daily Market Reports | Apr 22 2026
This story features AMPLITUDE ENERGY LIMITED, and other companies.
For more info SHARE ANALYSIS: AEL
The company is included in ASX300 and ALL-ORDS
An additional news report on the recommendation, valuation, forecast and opinion changes and updates for ASX-listed equities.
In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now added The Australian Broker Call *Extra* Edition, featuring additional sources of research and insights on ASX-listed stocks, also enlarging the number of stocks that make up the FNArena universe.
One key difference is the *Extra* Edition will not be updated daily, but merely “regularly” depending on availability of suitable quality content. As such, the *Extra* Edition tries to build a bridge between daily updates via the Australian Broker Call Report and ad hoc news stories, that are not always timely for investors hungry for the next information update.
Investors using the *Extra* Edition as a source of input for their own share market research should thus take into account that information after publication may not be up to date, or yet awaiting another update by FNArena’s team of journalists.
Similar to The Australian Broker Call Report, this *Extra* Edition includes concise but limited reviews of research recently published by Stockbrokers and other experts, which should be considered as information concerning likely market behaviour rather than advice on the securities mentioned. Do not act on the contents of this Report without first reading the important information included at the end of this Report.
The Australian Broker Call *Extra* Edition is a summary that has been prepared independently of the sources identified. Readers will check the full text of the recommendations and consult a Licenced Advisor before making any investment decision.
The copyright of this Report is owned by the publisher. Readers will not copy, forward or disseminate this Report to any other person. For more vital information about the sources included, see the bottom of this Report.
COMPANIES DISCUSSED IN THIS ISSUE
Click on a symbol for fast access.
The number next to the symbol represents the number of brokers covering it for this report -(if more than 1)
AEL (2) ARB ASK AVH BOQ BOT EBR GMD HZR JHX MAF MPK NAB NXT OCC PDN PLY QUB SKS SYL TNE
AEL AMPLITUDE ENERGY LIMITED
Crude Oil – Overnight Price: $1.57
Canaccord Genuity rates ((AEL)) as Speculative Buy (1) –
Canaccord Genuity downgrades its rating for Amplitude Energy to Speculative Buy and reduces the price target to $2.84 following exploration failures.
Operational performance remains strong with the Orbost plant delivering successful production trials at the upper end of guidance.
Record average gas prices of $10.74/GJ lifted revenue to a quarterly record of $74.1m, driven by legacy agreement renegotiations.
The analysts increased FY26 and FY27 EBITDA by 2% due to higher spot price assumptions linked to energy market volatility.
A binding gas sales agreement with AGL Energy ((AGL)) provides future supply certainty, subject to success in the upcoming drilling campaign.
This report was published on April 21, 2026.
Target price is $2.84 Current Price is $1.57 Difference: $1.265
If AEL meets the Canaccord Genuity target it will return approximately 80% (excluding dividends, fees and charges).
Current consensus price target is $2.91, suggesting upside of 84.3%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 0.00 cents and EPS of 21.80 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 7.22.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 21.0, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 7.5.
Forecast for FY27:
Canaccord Genuity forecasts a full year FY27 dividend of 0.00 cents and EPS of 23.60 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 6.67.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 25.1, implying annual growth of 19.5%.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 6.3.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
Jarden rates ((AEL)) as Overweight (2) –
Jarden maintains an Overweight rating and $2.15 target price for Amplitude Energy despite a quarterly revenue miss.
March quarter sales revenue of $74.1m fell -5% below estimates as low Victorian spot gas prices drove customers to nominate lower contracted volumes.
Production of 1.12 mmboe met consensus, reflecting strong output from the Orbost Gas Processing Plant which recently achieved record daily rates.
Management leaves FY26 guidance unchanged but expects tracking towards the upper end of its range as plant upgrades allow higher production.
Sentiments should improve with the next Otway drilling wave, including the Juliet exploration and Annie development wells in early FY27.
This report was published on April 20, 2026.
Target price is $2.15 Current Price is $1.57 Difference: $0.575
If AEL meets the Jarden target it will return approximately 37% (excluding dividends, fees and charges).
Current consensus price target is $2.91, suggesting upside of 84.3%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Jarden forecasts a full year FY26 dividend of 0.00 cents and EPS of 17.10 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 9.21.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 21.0, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 7.5.
Forecast for FY27:
Jarden forecasts a full year FY27 dividend of 0.00 cents and EPS of 28.60 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 5.51.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 25.1, implying annual growth of 19.5%.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 6.3.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
ARB ARB CORPORATION LIMITED
Automobiles & Components – Overnight Price: $20.29
Canaccord Genuity rates ((ARB)) as Hold (3) –
Canaccord Genuity maintains a Hold rating and reduces its target price for ARB Corp to $21.80, citing continued weakness in the Australian aftermarket.
Analysts identify unrealistic consensus forecasts for the second half of 2026 given cooling sales data across key vehicle classes.
Momentum in the US division is expected to slow as the business cycles through initial model launches and faces currency headwinds.
Proposed changes to US metal tariffs present additional downside risk to margins, though detailed clarity is still required.
Valuation multiples were adjusted downward to reflect these earnings revisions and broader market caution.
This report was published on April 20, 2026.
Target price is $21.80 Current Price is $20.29 Difference: $1.51
If ARB meets the Canaccord Genuity target it will return approximately 7% (excluding dividends, fees and charges).
Current consensus price target is $26.42, suggesting upside of 30.2%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 61.00 cents and EPS of 101.00 cents.
At the last closing share price the estimated dividend yield is 3.01%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 20.09.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 105.2, implying annual growth of -10.7%.
Current consensus DPS estimate is 70.8, implying a prospective dividend yield of 3.5%.
Current consensus EPS estimate suggests the PER is 19.3.
Forecast for FY27:
Canaccord Genuity forecasts a full year FY27 dividend of 64.00 cents and EPS of 107.00 cents.
At the last closing share price the estimated dividend yield is 3.15%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 18.96.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 117.3, implying annual growth of 11.5%.
Current consensus DPS estimate is 71.3, implying a prospective dividend yield of 3.5%.
Current consensus EPS estimate suggests the PER is 17.3.
Market Sentiment: 0.8
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
ASK ABACUS STORAGE KING
REITs – Overnight Price: $1.44
Shaw and Partners rates ((ASK)) as Buy (1) –
Shaw and Partners upgrades Abacus Storage King to Buy from Hold with a $1.65 target price following recent share price weakness.
The analysts identify potential catalysts including the internalisation of the management function and the delisting of National Storage REIT ((NSR)) leaving Abacus Storage as the only pure-play listed self-storage exposure.
Mapping of the existing portfolio indicates an incremental $40-45m in EBITDA growth through FY32, representing a 35% increase from current levels.
Profit expansion across the 105 established stores will be driven by price optimisation using the newly implemented revenue management system.
The broker observes the stock trades at a -22% discount to FY27 NTA, significantly wider than the -15% discount for the broader A-REIT index.
This report was published on April 20, 2026.
Target price is $1.65 Current Price is $1.44 Difference: $0.215
If ASK meets the Shaw and Partners target it will return approximately 15% (excluding dividends, fees and charges).
Current consensus price target is $1.55, suggesting upside of 7.6%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Shaw and Partners forecasts a full year FY26 dividend of 6.20 cents and EPS of 6.20 cents.
At the last closing share price the estimated dividend yield is 4.32%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 23.15.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 6.8, implying annual growth of -69.1%.
Current consensus DPS estimate is 6.2, implying a prospective dividend yield of 4.3%.
Current consensus EPS estimate suggests the PER is 21.2.
Forecast for FY27:
Shaw and Partners forecasts a full year FY27 dividend of 6.40 cents and EPS of 6.40 cents.
At the last closing share price the estimated dividend yield is 4.46%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 22.42.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 7.1, implying annual growth of 4.4%.
Current consensus DPS estimate is 6.3, implying a prospective dividend yield of 4.4%.
Current consensus EPS estimate suggests the PER is 20.3.
Market Sentiment: 0.3
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
AVH AVITA MEDICAL INC
Pharmaceuticals & Biotech/Lifesciences – Overnight Price: $1.38
Canaccord Genuity rates ((AVH)) as Hold (3) –
Canaccord Genuity maintains a Hold rating and $1.25 price target for Avita Medical following encouraging preliminary data for its Cohealyx dermal template.
A prospective study showed a mean time-to-graft of 13.6 days for full-thickness skin defects, performing significantly faster than historical biologic matrix benchmarks.
3Q26 group revenue reached $3.2m, including a US sales debut of $300k across 115 units.
The broker remains cautious until final data regarding definitive closure times and infection resistance release in October 2026.
Normalised cash burn moderated this period with a $48m cash balance reported at quarter end.
This report was published on April 20, 2026.
Target price is $1.25 Current Price is $1.38 Difference: minus $0.13 (current price is over target).
If AVH meets the Canaccord Genuity target it will return approximately minus 9% (excluding dividends, fees and charges – negative figures indicate an expected loss).
The company’s fiscal year ends in December.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 0.00 cents and EPS of minus 56.00 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 2.46.
Forecast for FY27:
Canaccord Genuity forecasts a full year FY27 dividend of 0.00 cents and EPS of minus 25.07 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 5.50.
This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.5
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
BOQ BANK OF QUEENSLAND LIMITED
Banks – Overnight Price: $7.27
Jarden rates ((BOQ)) as Sell (5) –
Jarden maintains its Sell rating and $6.00 price target for Bank of Queensland following an industry assessment.
The broker observes the bank has a liability disadvantage stemming from an old growth strategy funded by securitisation.
The report suggests management should continue reshaping the deposit book as low-cost deposits come through expensive branches while high-cost deposits flow through digital channels.
The analysts consider originate-to-sell and other forms of capital engineering as unsustainable fair-weather tools.
Returning released capital to owners appears unusual for a bank with low organic capital generation and suppresses future growth potential, the report concludes.
This report was published on April 17, 2026.
Target price is $6.00 Current Price is $7.27 Difference: minus $1.27 (current price is over target).
If BOQ meets the Jarden target it will return approximately minus 17% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $6.84, suggesting downside of -5.9%(ex-dividends)
The company’s fiscal year ends in August.
Forecast for FY26:
Jarden forecasts a full year FY26 dividend of 40.00 cents and EPS of 55.00 cents.
At the last closing share price the estimated dividend yield is 5.50%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 13.22.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 57.4, implying annual growth of 184.0%.
Current consensus DPS estimate is 48.2, implying a prospective dividend yield of 6.6%.
Current consensus EPS estimate suggests the PER is 12.7.
Forecast for FY27:
Jarden forecasts a full year FY27 dividend of 44.00 cents and EPS of 60.00 cents.
At the last closing share price the estimated dividend yield is 6.05%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 12.12.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 61.5, implying annual growth of 7.1%.
Current consensus DPS estimate is 41.2, implying a prospective dividend yield of 5.7%.
Current consensus EPS estimate suggests the PER is 11.8.
Market Sentiment: 0.2
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
BOT BOTANIX PHARMACEUTICALS LIMITED
Pharmaceuticals & Biotech/Lifesciences – Overnight Price: $0.04
Canaccord Genuity rates ((BOT)) as Buy (1) –
Canaccord Genuity maintains a Buy rating and $0.14 price target for Botanix Pharmaceuticals following a $45m capital raise and revised US script projections.
Balance sheet pressure is now addressed through this new capital and renegotiated material purchase schedules.
Initial script data show signs of consistency, although the analysts expect a soft March quarter report following broad market weakness.
Future growth relies on onboarding new patients and achieving high refill rates over the coming year.
Peak sales targets are unchanged but deferred by 1 year due to these moderations.
This report was published on April 17, 2026.
Target price is $0.14 Current Price is $0.04 Difference: $0.104
If BOT meets the Canaccord Genuity target it will return approximately 289% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 0.00 cents and EPS of minus 2.60 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 1.38.
Forecast for FY27:
Canaccord Genuity forecasts a full year FY27 dividend of 0.00 cents and EPS of minus 2.00 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 1.80.
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
EBR EBR SYSTEMS INC
Medical Equipment & Devices – Overnight Price: $0.65
Canaccord Genuity rates ((EBR)) as Buy (1) –
Canaccord Genuity maintains a Buy rating and $2.43 target price for EBR Systems following recent clinical updates for the WiSE-CRT system.
A new case report demonstrates the first successful use of WiSE technology alongside Abbott’s leadless pacemaker in the US for a non-responsive heart failure patient.
The analyst observes the leadless pacemaker market is growing faster than internal assumptions, validating the company’s strategic focus.
Recent studies show conduction system pacing provides superior outcomes compared to traditional methods, highlighting potential new use cases for the septal electrode.
While this update focuses on technical milestones, the broker believes off-label usage in the US further validates clinical utility ahead of broader label expansion.
This report was published on April 20, 2026.
Target price is $2.43 Current Price is $0.65 Difference: $1.78
If EBR meets the Canaccord Genuity target it will return approximately 274% (excluding dividends, fees and charges).
The company’s fiscal year ends in December.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 0.00 cents and EPS of 0.00 cents.
Forecast for FY27:
Canaccord Genuity forecasts a full year FY27 dividend of 0.00 cents and EPS of 0.00 cents.
This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
GMD GENESIS MINERALS LIMITED
Gold & Silver – Overnight Price: $6.68
Shaw and Partners rates ((GMD)) as Buy (1) –
Shaw and Partners maintains a Buy rating and $10.00 price target for Genesis Minerals after March quarter production fell slightly below expectations.
The broker observes lower third-party ore purchases drove the headline weakness, while company-owned mines continue ramping up.
Commentary highlights operations at the Ulysses and Leonora sites are performing well, with higher stope grades and increased production expected from the final quarter of FY26.
The company remains debt-free with a strong $600m cash balance to fund its aspirational growth toward a 500kozpa production base.
Management intends to provide an updated multi-year outlook during the September quarter of 2026.
This report was published on April 20, 2026.
Target price is $10.00 Current Price is $6.68 Difference: $3.32
If GMD meets the Shaw and Partners target it will return approximately 50% (excluding dividends, fees and charges).
Current consensus price target is $9.33, suggesting upside of 39.7%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Shaw and Partners forecasts a full year FY26 dividend of 0.00 cents and EPS of 67.30 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 9.93.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 51.5, implying annual growth of 154.1%.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 13.0.
Forecast for FY27:
Shaw and Partners forecasts a full year FY27 dividend of 0.00 cents and EPS of 116.90 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 5.71.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 62.4, implying annual growth of 21.2%.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 10.7.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
HZR HAZER GROUP LIMITED
Overnight Price: $0.42
Shaw and Partners rates ((HZR)) as Buy (1) –
Shaw and Partners maintains a Buy rating and $0.70 price target for Hazer Group following the company’s March 2026 quarterly update.
Hazer achieved several milestones, including completing the Process Design Package with KBR for a 30 ktpa hydrogen facility.
Management signed a non-binding graphite offtake agreement with Green Steel WA for up to 85,000 tonnes, starting from 2030.
Commentary highlights independent testing confirmed the graphite product meets standards for concrete and asphalt market applications.
The business maintains a robust funding position of $15.3m following a -16% reduction in cash burn, the report concludes.
This report was published on April 21, 2026.
Target price is $0.70 Current Price is $0.42 Difference: $0.28
If HZR meets the Shaw and Partners target it will return approximately 67% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.
Forecast for FY26:
Shaw and Partners forecasts a full year FY26 dividend of 0.00 cents and EPS of minus 3.00 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 14.00.
Forecast for FY27:
Shaw and Partners forecasts a full year FY27 dividend of 0.00 cents and EPS of minus 3.50 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 12.00.
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
JHX JAMES HARDIE INDUSTRIES PLC
Building Products & Services – Overnight Price: $30.65
Jarden rates ((JHX)) as Overweight (2) –
Jarden maintains an Overweight rating and $34.90 target price for James Hardie Industries following a preview of the upcoming Q4 results.
The broker suggests the -18% share price sell-off since late February is an overreaction to geopolitical conflict not supported by fundamental earnings analysis.
Jarden expects a quarterly beat driven by strong Siding and Trim performance alongside lower pulp costs.
While FY27 guidance should align with consensus, freight cost inflation remains a near-term headwind.
The stock currently trades at a -20% discount to its 10-year average valuation multiple, the broker points out.
This report was published on April 18, 2026.
Target price is $34.90 Current Price is $30.65 Difference: $4.25
If JHX meets the Jarden target it will return approximately 14% (excluding dividends, fees and charges).
Current consensus price target is $41.16, suggesting upside of 34.3%(ex-dividends)
The company’s fiscal year ends in March.
Forecast for FY26:
Jarden forecasts a full year FY26 dividend of 0.00 cents and EPS of 170.10 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 18.02.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 153.8, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 19.9.
Forecast for FY27:
Jarden forecasts a full year FY27 dividend of 0.00 cents and EPS of 188.56 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 16.25.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 176.1, implying annual growth of 14.5%.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 17.4.
This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.7
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
MAF MA FINANCIAL GROUP LIMITED
Wealth Management & Investments – Overnight Price: $7.53
Canaccord Genuity rates ((MAF)) as Buy (1) –
Canaccord Genuity maintains a Buy rating and $11.30 price target for MA Financial following a Q126 update highlighting strong momentum in the Priority Income Fund.
The broker expects net inflows of $430m, excluding the Marion mandate loss and MA Aged Care fund wind-up. Managed assets are targeting an ending balance of $15.1bn, while the Redcape property fund delivered 2.93% quarterly performance to support possible 2H26 performance fees.
Strategic expansion into commercial lending targets average monthly settlements of $1bn, coimmentary highlights, which would provide a significant contribution relative to historical levels.
Management remains cautious of consumer strain impacts on MA Money loan losses, but anticipates credit quality concerns will abate as offshore markets stabilise.
This report was published on April 20, 2026.
Target price is $11.30 Current Price is $7.53 Difference: $3.77
If MAF meets the Canaccord Genuity target it will return approximately 50% (excluding dividends, fees and charges).
Current consensus price target is $10.71, suggesting upside of 42.3%(ex-dividends)
The company’s fiscal year ends in December.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 20.00 cents and EPS of 46.00 cents.
At the last closing share price the estimated dividend yield is 2.66%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 16.37.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 48.1, implying annual growth of 670.8%.
Current consensus DPS estimate is 27.8, implying a prospective dividend yield of 3.7%.
Current consensus EPS estimate suggests the PER is 15.7.
Forecast for FY27:
Canaccord Genuity forecasts a full year FY27 dividend of 20.00 cents and EPS of 59.00 cents.
At the last closing share price the estimated dividend yield is 2.66%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 12.76.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 58.3, implying annual growth of 21.2%.
Current consensus DPS estimate is 33.6, implying a prospective dividend yield of 4.5%.
Current consensus EPS estimate suggests the PER is 12.9.
Market Sentiment: 0.8
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
MPK MANY PEAKS MINERALS LIMITED
Mining – Overnight Price: $1.24
Canaccord Genuity rates ((MPK)) as Speculative Buy (1) –
Canaccord Genuity maintains a Speculative Buy rating and $1.85 price target for Many Peaks Minerals after the maiden JORC resource at the Ferke Gold Project exceeded expectations.
The 1.32m ounce at 1.54g/t gold resource provides a high-confidence foundation with 83% classified as Measured and Indicated.
Mineralisation demonstrates strong vertical continuity down to -540m depth, supporting potential for simple bulk open-pit mining.
Grade results were approximately 30% higher than consensus, with low discovery costs of $8 per ounce highlighting favourable early-stage economics, the broker points out.
Canaccord Genuity expects resource growth and an updated study following further modelling towards completion in the December quarter of 2026.
This report was published on April 19, 2026.
Target price is $1.85 Current Price is $1.24 Difference: $0.61
If MPK meets the Canaccord Genuity target it will return approximately 49% (excluding dividends, fees and charges).
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
NAB NATIONAL AUSTRALIA BANK LIMITED
Banks – Overnight Price: $41.21
Jarden rates ((NAB)) as Sell (5) –
Jarden reiterates its Sell rating and $30.00 price target for National Australia Bank following this week’s market update that included “significant” capital and accounting correction.
The bank announced an $1.8bn equity raise via a partial underwrite of its dividend reinvestment plan to address a persistent under-capitalisation relative to major peers.
Jarden observes NAB has historically over-earned by approximately $300m annually by capitalising a much higher proportion of software expenses than its competitors.
The stock remains over-owned by domestic institutions and trades at an elevated 21x price-to-earnings multiple compared to its long-term average of 12x, commentary points out.
The conclusion drawn is that future growth prospects appear limited as the bank pivots from share buybacks to equity issuance to preserve its balance sheet integrity.
This report was published on April 20, 2026.
Target price is $30.00 Current Price is $41.21 Difference: minus $11.21 (current price is over target).
If NAB meets the Jarden target it will return approximately minus 27% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $40.44, suggesting downside of -1.9%(ex-dividends)
The company’s fiscal year ends in September.
Forecast for FY26:
Jarden forecasts a full year FY26 dividend of 171.00 cents and EPS of 207.70 cents.
At the last closing share price the estimated dividend yield is 4.15%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 19.84.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 226.7, implying annual growth of 2.6%.
Current consensus DPS estimate is 171.2, implying a prospective dividend yield of 4.2%.
Current consensus EPS estimate suggests the PER is 18.2.
Forecast for FY27:
Jarden forecasts a full year FY27 dividend of 171.00 cents and EPS of 240.10 cents.
At the last closing share price the estimated dividend yield is 4.15%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 17.16.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 252.0, implying annual growth of 11.2%.
Current consensus DPS estimate is 172.6, implying a prospective dividend yield of 4.2%.
Current consensus EPS estimate suggests the PER is 16.4.
Market Sentiment: -0.5
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
NXT NEXTDC LIMITED
Cloud services – Overnight Price: $14.12
Canaccord Genuity rates ((NXT)) as Buy (1) –
Canaccord Genuity maintains a Buy rating and raises the price target for NextDC to $22.55 following the company’s largest-ever contract win.
Commentary posits securing 250MW of new capacity at the S4 site provides significantly enhanced earnings visibility over the next four to five years.
The analysts observe the business is now tracking towards a contracted EBITDA exceeding $1bn per year, likely achieving a full run-rate by the 2030 financial year.
Funding for this massive expansion is secured through a $1.5bn equity raise and an incremental $700m in hybrid securities.
Revised estimates for the 2028 financial year include an upgraded EBITDA forecast of $632m to reflect early contributions from the new capacity.
This report was published on April 21, 2026.
Target price is $22.55 Current Price is $14.12 Difference: $8.43
If NXT meets the Canaccord Genuity target it will return approximately 60% (excluding dividends, fees and charges).
Current consensus price target is $19.98, suggesting upside of 41.5%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 0.00 cents and EPS of 0.00 cents.
How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is -18.6, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is N/A.
Forecast for FY27:
Canaccord Genuity forecasts a full year FY27 dividend of 0.00 cents and EPS of 0.00 cents.
How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is -30.6, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is N/A.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
OCC ORTHOCELL LIMITED
Pharmaceuticals & Biotech/Lifesciences – Overnight Price: $0.94
Canaccord Genuity rates ((OCC)) as Speculative Buy (1) –
Canaccord Genuity maintains a Speculative Buy rating and $1.26 price target for Orthocell following the 3Q26 update.
Group revenue of $3.2m for the quarter brought the year-to-date total to $9.4m, representing a 45% increase versus the previous period.
US sales debuted during this quarter with $300,000 in revenue from the Remplir product launch.
The valuation is lowered, primarily due to currency fluctuations as the AUD strengthened against the USD.
Commentary observes normalised cash burn moderated during the period, with the company reporting $48m in cash at the end of the quarter.
This report was published on April 20, 2026.
Target price is $1.26 Current Price is $0.94 Difference: $0.315
If OCC meets the Canaccord Genuity target it will return approximately 33% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 0.00 cents and EPS of minus 4.20 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 22.50.
Forecast for FY27:
Canaccord Genuity forecasts a full year FY27 dividend of 0.00 cents and EPS of minus 1.90 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 49.74.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
PDN PALADIN ENERGY LIMITED
Uranium – Overnight Price: $13.61
Canaccord Genuity rates ((PDN)) as Buy (1) –
Canaccord Genuity maintains a Buy rating and $16.00 price target for Paladin Energy as operational outperformance drives a production guidance upgrade.
Success in mobilising the mining fleet alongside improved feed grades and high recovery rates allowed management to raise the FY26 production range to 4.5-4.8Mlbs.
Production during the March quarter reached 1,290Klbs, exceeding internal forecasts by 5%.
Despite strong output, the broker increased FY27 unit cost estimates to $44/lb to reflect potential supply chain risks within Southern Africa.
Sales volumes trailed production this period but realised prices are expected to trend higher toward the mid-US$70s for the remainder of 2026.
This report was published on April 20, 2026.
Target price is $16.00 Current Price is $13.61 Difference: $2.39
If PDN meets the Canaccord Genuity target it will return approximately 18% (excluding dividends, fees and charges).
Current consensus price target is $12.95, suggesting downside of -4.8%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 0.00 cents and EPS of 5.10 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 266.65.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 6.6, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 206.2.
Forecast for FY27:
Canaccord Genuity forecasts a full year FY27 dividend of 0.00 cents and EPS of 17.27 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 78.83.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 33.2, implying annual growth of 403.0%.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 41.0.
This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.3
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
PLY PLAYSIDE STUDIOS LIMITED
Gaming – Overnight Price: $0.33
Canaccord Genuity rates ((PLY)) as Buy (1) –
Canaccord Genuity maintains a Buy rating and $0.60 price target for PlaySide Studios following the successful launch of the company’s largest original title, Mouse P.I. for Hire.
The game achieved unit sales of approximately 360,000 and net revenue of $9.0m within the first 48 hours, placing the company on track to recoup publishing costs well ahead of schedule.
Canaccord Genuity highlights significant upside potential to FY26 revenue forecasts as current estimates exclude console contributions and seasonal sale events.
Strong initial review scores and top-seller chart placement on Steam and PlayStation validate the company’s full-stack development and multi-platform execution capabilities.
Successful delivery of this major IP serves as a tangible showcase to strengthen the company’s competitive position in pursuing future high-quality work-for-hire contracts, the report concludes.
This report was published on April 20, 2026.
Target price is $0.60 Current Price is $0.33 Difference: $0.275
If PLY meets the Canaccord Genuity target it will return approximately 85% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 0.00 cents and EPS of 1.30 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 25.00.
Forecast for FY27:
Canaccord Genuity forecasts a full year FY27 dividend of 0.00 cents and EPS of 1.80 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 18.06.
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
QUB QUBE HOLDINGS LIMITED
Transportation & Logistics – Overnight Price: $4.98
Jarden rates ((QUB)) as Neutral (3) –
Jarden retains its Neutral rating and $5.00 target price for Qube Holdings following a 2H26 trading update highlighting operational headwinds from rising fuel and shipping costs.
Conflicts in the Middle East and domestic weather disruptions in Western Australia and New Zealand are expected to reduce underlying earnings by approximately -$13m to -$25m.
Management has withdrawn its previous growth guidance of 6% to 10% but still expects positive underlying earnings growth for the 2026 financial year.
The analysts observe information flow regarding the Macquarie Asset Management ((MQG)) binding offer remains the primary share price driver as ACCC regulatory reviews progress toward a mid-June deadline.
Modest downward revisions to EPS forecasts for FY26 and FY27 reflect higher energy-related costs within the logistics division.
This report was published on April 20, 2026.
Target price is $5.00 Current Price is $4.98 Difference: $0.02
If QUB meets the Jarden target it will return approximately 0% (excluding dividends, fees and charges).
Current consensus price target is $5.17, suggesting upside of 3.7%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Jarden forecasts a full year FY26 dividend of 8.90 cents and EPS of 14.50 cents.
At the last closing share price the estimated dividend yield is 1.79%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 34.34.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 18.6, implying annual growth of 190.6%.
Current consensus DPS estimate is 11.0, implying a prospective dividend yield of 2.2%.
Current consensus EPS estimate suggests the PER is 26.8.
Forecast for FY27:
Jarden forecasts a full year FY27 dividend of 11.20 cents and EPS of 17.70 cents.
At the last closing share price the estimated dividend yield is 2.25%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 28.14.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 19.2, implying annual growth of 3.2%.
Current consensus DPS estimate is 12.0, implying a prospective dividend yield of 2.4%.
Current consensus EPS estimate suggests the PER is 25.9.
Market Sentiment: 0.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
SKS SKS TECHNOLOGIES GROUP LIMITED
Technology – Overnight Price: $6.41
Canaccord Genuity rates ((SKS)) as Buy (1) –
Canaccord Genuity maintains a Buy rating and $6.47 price target for SKS Technologies following an $80m contract win for a Melbourne hyperscale data centre.
This award takes total work won at the site to $210m and increases confidence in the FY27 revenue pathway approaching $500m.
FY27 revenue estimates have been upgraded by 15% and PBT by 20% to reflect accelerating momentum in the Victorian data centre market.
Operating leverage should drive PBT margins to 11.2% by FY28 as the business benefits from scale and the Delta acquisition.
The broker explains its new target price reflects a 13x EV/EBITDA multiple which remains conservative relative to domestic peers despite the superior 37% EBITDA growth rate.
This report was published on April 17, 2026.
Target price is $6.47 Current Price is $6.41 Difference: $0.06
If SKS meets the Canaccord Genuity target it will return approximately 1% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 9.70 cents and EPS of 21.50 cents.
At the last closing share price the estimated dividend yield is 1.51%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 29.81.
Forecast for FY27:
Canaccord Genuity forecasts a full year FY27 dividend of 9.70 cents and EPS of 30.00 cents.
At the last closing share price the estimated dividend yield is 1.51%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 21.37.
Market Sentiment: 0.5
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
SYL SYMAL GROUP LIMITED
Industrial Sector Contractors & Engineers – Overnight Price: $2.49
Canaccord Genuity rates ((SYL)) as Initiation of coverage with Buy (1) –
Canaccord Genuity initiates coverage of Symal Group with a Buy rating and $3.50 price target.
The civil construction group delivers infrastructure services across transport, utilities, and resources markets on the Australian east coast.
Canaccord Genuity expects material growth from upcoming contract awards in Queensland and South Australia, including AUKUS-related works and the Brisbane Olympics.
A vertically integrated business model helps reduce supply chain risks while providing pricing certainty for the $1.4bn project pipeline, commentary suggests.
Although 2026 represents a year of investment and expansion, the broker believes these strategic opportunities should attract significant investor interest as they move closer.
This report was published on April 21, 2026.
Target price is $3.50 Current Price is $2.49 Difference: $1.01
If SYL meets the Canaccord Genuity target it will return approximately 41% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 8.50 cents and EPS of 21.10 cents.
At the last closing share price the estimated dividend yield is 3.41%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 11.80.
Forecast for FY27:
Canaccord Genuity forecasts a full year FY27 dividend of 9.40 cents and EPS of 23.10 cents.
At the last closing share price the estimated dividend yield is 3.78%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 10.78.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
TNE TECHNOLOGY ONE LIMITED
IT & Support – Overnight Price: $30.01
Jarden rates ((TNE)) as Downgrade to Neutral from Buy (3) –
Jarden downgrades TechnologyOne to Neutral from Buy while maintaining a $30.00 target price following recent share price strength.
The broker observes the 30% rally since mid-February leaves the stock trading at 62.4x FY26 earnings, suggesting future growth is largely priced in.
Jarden expects a strong 1H26 result with revenue growth of 13% to $323m, although higher showcase event costs of -$8m-$9m will limit profit before tax growth to a high single digit percentage.
Medium-term estimates for FY27 and FY28 see upgrades due to a higher annual recurring revenue outlook of $1.13bn by FY30.
Strategic risks include increased AI-led competition and the potential rationalisation of technology spend due to local council mergers.
This report was published on April 20, 2026.
Target price is $30.00 Current Price is $30.01 Difference: minus $0.01 (current price is over target).
If TNE meets the Jarden target it will return approximately minus 0% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $32.49, suggesting upside of 8.3%(ex-dividends)
The company’s fiscal year ends in September.
Forecast for FY26:
Jarden forecasts a full year FY26 dividend of 32.10 cents and EPS of 48.90 cents.
At the last closing share price the estimated dividend yield is 1.07%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 61.37.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 49.5, implying annual growth of 17.5%.
Current consensus DPS estimate is 33.6, implying a prospective dividend yield of 1.1%.
Current consensus EPS estimate suggests the PER is 60.6.
Forecast for FY27:
Jarden forecasts a full year FY27 dividend of 40.40 cents and EPS of 61.50 cents.
At the last closing share price the estimated dividend yield is 1.35%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 48.80.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 58.6, implying annual growth of 18.4%.
Current consensus DPS estimate is 39.2, implying a prospective dividend yield of 1.3%.
Current consensus EPS estimate suggests the PER is 51.2.
Market Sentiment: 0.8
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
Disclaimer:
The content of this information does in no way reflect the opinions of FNArena, or of its journalists. In fact we don’t have any opinion about the stock market, its value, future direction or individual shares. FNArena solely reports about what the main experts in the market note, believe and comment on. By doing so we believe we provide experienced, intelligent investors with a valuable tool that helps them in making up their own minds, reading market trends and getting a feel for what is happening beneath the surface.
This document is provided for informational purposes only. It does not constitute an offer to sell or a solicitation to buy any security or other financial instrument. FNArena employs very experienced journalists who base their work on information believed to be reliable and accurate, though no guarantee is given that the daily report is accurate or complete. Investors should contact their personal adviser before making any investment decision.
Click to view our Glossary of Financial Terms
CHARTS
For more info SHARE ANALYSIS: AEL - AMPLITUDE ENERGY LIMITED
For more info SHARE ANALYSIS: AGL - AGL ENERGY LIMITED
For more info SHARE ANALYSIS: ARB - ARB CORPORATION LIMITED
For more info SHARE ANALYSIS: ASK - ABACUS STORAGE KING
For more info SHARE ANALYSIS: AVH - AVITA MEDICAL INC
For more info SHARE ANALYSIS: BOQ - BANK OF QUEENSLAND LIMITED
For more info SHARE ANALYSIS: BOT - BOTANIX PHARMACEUTICALS LIMITED
For more info SHARE ANALYSIS: EBR - EBR SYSTEMS INC
For more info SHARE ANALYSIS: GMD - GENESIS MINERALS LIMITED
For more info SHARE ANALYSIS: HZR - HAZER GROUP LIMITED
For more info SHARE ANALYSIS: JHX - JAMES HARDIE INDUSTRIES PLC
For more info SHARE ANALYSIS: MAF - MA FINANCIAL GROUP LIMITED
For more info SHARE ANALYSIS: MPK - MANY PEAKS MINERALS LIMITED
For more info SHARE ANALYSIS: MQG - MACQUARIE GROUP LIMITED
For more info SHARE ANALYSIS: NAB - NATIONAL AUSTRALIA BANK LIMITED
For more info SHARE ANALYSIS: NSR - NATIONAL STORAGE REIT
For more info SHARE ANALYSIS: NXT - NEXTDC LIMITED
For more info SHARE ANALYSIS: OCC - ORTHOCELL LIMITED
For more info SHARE ANALYSIS: PDN - PALADIN ENERGY LIMITED
For more info SHARE ANALYSIS: PLY - PLAYSIDE STUDIOS LIMITED
For more info SHARE ANALYSIS: QUB - QUBE HOLDINGS LIMITED
For more info SHARE ANALYSIS: SKS - SKS TECHNOLOGIES GROUP LIMITED
For more info SHARE ANALYSIS: SYL - SYMAL GROUP LIMITED
For more info SHARE ANALYSIS: TNE - TECHNOLOGY ONE LIMITED